FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos Nos

Research Profile

Disorders

Procedures

Disability Evaluation

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
S Otero-Romero; P Roura; Jaume Sastre-Garriga; J Solà; J Vaqué; J Altimiras; Xavier Montalban; Carlos Nos; E Bufill
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Carmen Tur; M José Vicente; Angela Vidal-Jordana; Carlos Nos; Jordi Río; Jaume Sastre-Garriga; Mar Tintoré; M Jesús Arévalo; Georgina Arrambide; Ana Caminero; Joaquín Castilló; Manuel Comabella; Ingrid Galán; Rosalía Horno; Xavier Montalban
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
C Costa; Alejandro Horga; Georgina Arrambide; C Auger; J Castilló; Manuel Comabella; Carlos Nos; Jordi Río; Alex Rovira; Albert Saiz; Jaume Sastre-Garriga; Mar Tintore; C Tur; A Vidal-Jordana; Xavier Montalban
Value of NMO-IgG determination at the time of presentation as CIS.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos Nos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Otero-Romero; P Roura; Jaume Sastre-Garriga; J Solà; J Vaqué; J Altimiras; Xavier Montalban; Carlos Nos; E Bufill
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(2):245-8.
2012: Carmen Tur; M José Vicente; Angela Vidal-Jordana; Carlos Nos; Jordi Río; Jaume Sastre-Garriga; Mar Tintoré; M Jesús Arévalo; Georgina Arrambide; Ana Caminero; Joaquín Castilló; Manuel Comabella; Ingrid Galán; Rosalía Horno; Xavier Montalban
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(8):1193-6.
2012: C Costa; Alejandro Horga; Georgina Arrambide; C Auger; J Castilló; Manuel Comabella; Carlos Nos; Jordi Río; Alex Rovira; Albert Saiz; Jaume Sastre-Garriga; Mar Tintore; C Tur; A Vidal-Jordana; Xavier Montalban
Value of NMO-IgG determination at the time of presentation as CIS.
Neurology 2012;78(20):1608-11.
2011: Carmen Tur; Jaume Sastre-Garriga; Nieves Téllez; Mar Tintoré; Francesc Xavier Aymerich; Luis Brieva; David Calle; Manuel Comabella; Ingrid Galán; Xavier Montalban; Carlos Nos; Héctor Perkal; Jordi Río; Alex Rovira
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Archives of neurology 2011;68(11):1421-7.
2011: Alejandro Horga; J Castillo; J Rio; Mar Tintore; C Auger; J Sastre-Garriga; M C Edo; Francisco Carlos Pérez-Miralles; C Tur; Carlos Nos; E Huerga; Manuel Comabella; Alex Rovira; Xavier Montalban
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.
Revista de neurologia 2011;52(6):321-30.
2010: Mar Tintore; Alex Rovira; Georgina Arrambide; R Mitjana; Jordi Río; C Auger; Carlos Nos; M C Edo; J Castilló; Alejandro Horga; Francisco Carlos Pérez-Miralles; E Huerga; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Brainstem lesions in clinically isolated syndromes.
Neurology 2010;75(21):1933-8.
2010: Jaume Sastre-Garriga; Mar Tintoré; Carlos Nos; C Tur; Jordi Río; Nieves Téllez; J Castilló; Alejandro Horga; H Perkal; Manuel Comabella; Alex Rovira; Xavier Montalban
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
Journal of neurology 2010;257(5):742-6.
2009: Manuel Comabella; Jordi Río; Carmen Espejo; Mamen Ruiz de Villa; Hammad Al-Zayat; Carlos Nos; Florian Deisenhammer; Sergio E Baranzini; Lara Nonell; Cristina López; Eva Julià; Jorge R Oksenberg; Xavier Montalban
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2009;130(2):145-50.
2008: Robert Goertsches; Sergio E Baranzini; Carlos Morcillo; Carlos Nos; Montse Camiña; Jorge R Oksenberg; Xavier Montalban; Manuel Comabella
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(3):412-4.
2008: Mar Tintoré; Alex Rovira; Jordi Río; C Tur; Raul Pelayo; Carlos Nos; Nieves Téllez; H Perkal; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Neurology 2008;70(13 Pt 2):1079-83.
2008: Nieves Téllez; J Alonso; J Río; Mar Tintoré; Carlos Nos; Xavier Montalban; Alex Rovira
The basal ganglia: a substrate for fatigue in multiple sclerosis.
Neuroradiology 2008;50(1):17-23.
2007: Raul Pelayo; Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisenda Grivé; Nieves Téllez; Manuel Comabella; Xavier Montalban
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(6):731-6.
2007: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Raul Pelayo; Xavier Montalban
Interferon beta in secondary progressive multiple sclerosis : daily clinical practice.
Journal of neurology 2007;254(7):849-53.
2006: Joana Porcel; Jordi Río; A Sánchez-Betancourt; M J Arévalo; Mar Tintoré; Nieves Téllez; Cecília Borràs; Carlos Nos; Xavier Montalbán
Long-term emotional state of multiple sclerosis patients treated with interferon beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):802-7.
2006: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Fatigue in multiple sclerosis persists over time: a longitudinal study.
Journal of neurology 2006;253(11):1466-70.
2006: Mar Tintoré; Alex Rovira; Jordi Río; Carlos Nos; Elisenda Grivé; Nieves Téllez; Raul Pelayo; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Neurology 2006;67(6):968-72.
2006: Nieves Téllez; Manuel Comabella; Eva Julià; Jordi Río; Mar Tintoré; Luis Brieva; Carlos Nos; Xavier Montalban
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(4):487-94.
2006: M Rubiera; Jordi Río; Mar Tintoré; Carlos Nos; Alex Rovira; Nieves Téllez; Xavier Montalban
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.
Neurology 2006;66(10):1568-70.
2006: Marta Aymerich; Imma Guillamón; H Perkal; Carlos Nos; J Porcel; Silvina Berra; Luis Rajmil; Xavier Montalbán
[Spanish adaptation of the disease-specific questionnaire MSQOL-54 in multiple sclerosis patients].
Neurología (Barcelona, Spain) 2006;21(4):181-7.
2006: Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raul Pelayo; Manuel Comabella; Xavier Montalban
Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients.
Annals of neurology 2006;59(2):344-52.
2005: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Xavier Montalban
Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
Journal of neurology 2005;252(7):795-800.
2005: Jordi Río; Joana Porcel; Nieves Téllez; Angela Sánchez-Betancourt; Mar Tintoré; M Jesús Arévalo; Carlos Nos; Xavier Montalban
Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(3):306-9.
2005: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(2):198-202.
2005: Jordi Río; Mar Tintoré; Nieves Téllez; Carlos Nos; Ingrid Galán; Xavier Montalbán
[Long-term effect of neutralizing antibodies to interferon beta-1 b in patients with multiple sclerosis].
Medicina clínica 2005;124(4):140-1.
2005: Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisenda Grivé; Nieves Téllez; Raul Pelayo; Manuel Comabella; Xavier Montalban
Is optic neuritis more benign than other first attacks in multiple sclerosis?
Annals of neurology 2005;57(2):210-5.
2005: Manuel Comabella; Imma Pericot; Robert Goertsches; Carlos Nos; Mireia Castillo; José Blas Navarro; Jordi Río; Xavier Montalban
Plasma osteopontin levels in multiple sclerosis.
Journal of neuroimmunology 2005;158(1-2):231-9.
2004: Jordi Río; Carlos Nos; I Bonaventura; R Arroyo; D Genis; B Sureda; JR Ara; Luis Brieva; J Martín; Albert Saiz; F Sánchez López; J M Prieto; J Roquer; J F Dorado; Xavier Montalban
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial.
Neurology 2004;63(3):525-8.
2004: Carlos Nos; Jaume Sastre-Garriga; Cecília Borràs; Jordi Río; Mar Tintoré; Xavier Montalban
Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):413-6.
2004: Jaume Sastre-Garriga; Mar Tintoré; Alex Rovira; Carlos Nos; Jordi Río; Alan J Thompson; Xavier Montalban
Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes.
Archives of neurology 2004;61(2):222-4.
2003: Imma Pericot; Luis Brieva; Mar Tintoré; Jordi Río; Jaume Sastre-Garriga; Carlos Nos; Xavier Montalban
Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):256-9.
2003: Mar Tintoré; Alex Rovira; Jordi Río; Carlos Nos; Elisenda Grivé; Jaume Sastre-Garriga; Imma Pericot; E Sánchez; Manuel Comabella; Xavier Montalban
New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.
Neurology 2003;60(1):27-30.
2002: Jordi Río; Carlos Nos; Mar Tintoré; Cecilia Borrás; Ingrid Galán; Manuel Comabella; Xavier Montalban
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.
Annals of neurology 2002;52(4):400-6.
2002: Jaume Sastre-Garriga; Jordi Río; Carlos Nos; Ingrid Galán; Mar Tintoré; Xavier Montalbán
[Descriptive study of first visits in a multiple sclerosis specialised unit].
Neurología (Barcelona, Spain) 2002;17(4):179-82.
1999: Alex Rovira; Juli Alonso; G Cucurella; Carlos Nos; Mar Tintoré; Salvador Pedraza; J Rio; Xavier Montalban
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
AJNR. American journal of neuroradiology 1999;20(10):1939-45.
1997: Jordi Río; Carlos Nos; Alex Rovira; Mar Tintoré; Agusti Codina; Xavier Montalbán
[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study].
Medicina clínica 1997;109(10):370-2.
1996: Carlos Nos; M Comabella; Mar Tintoré; J Rio; Agusti Codina; Xavier Montalban; A Rovira
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1996;61(4):418.
1996: P Díaz-Villoslada; Carlos Nos; José Alvarez-Sabín
[Dysphagia, dysphonia and Horner's syndrome as a form of presentation of right subclavian artery aneurysm].
Revista de neurologia 1996;24(131):868.
1994: P Díaz-Villoslada; M Lozano; Carlos Nos; M Comabella; J Montalbán; Agusti Codina
[Syphilitic meningoradiculitis in a patient with HIV].
Neurología (Barcelona, Spain) 1994;9(6):253-5.